ArticlePLoS neglected tropical diseases2026
A functional crosstalk between circulating follicular helper 2 T cells and memory B cells drives anti-Plasmodium vivax antibodies.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe induction of long-term humoral immune responses depends upon the interaction between T follicular helper (Tfh) and B cells in germinal centers, leading to development of memory B cells (MBCs) and class-switched antibodies. Expansion and activation of circulating Tfh2 (cTfh2) cells were detected in both vivax and falciparum malaria subjects. However, how these cells help B cells generate anti-malarial immunity is still unclear. Here, we assessed the breadth and competency of antibody responses from P. vivax subjects and related them to the frequency and activation status of cTfh2 subset. We also demonstrated the ability of P. vivax antigen to trigger cTfh2 cell activation and the function of cTfh2 cells to help MBCs secrete antibodies. METHODOLOGY/PRINCIPAL
findingsOf 40 subjects with acute P. vivax malaria, 23 were seropositive for anti-PvDBPII antibodies (High and Low responders). Three High Responders (HRs) produced inhibitory antibodies against PvDBPII-human erythrocyte binding. An expansion of cTfh2 cells was detected in seropositive subjects. While their frequency did not differ significantly between High and Low Responders (LRs), the expression of co-stimulatory molecule ICOS in cTfh2 cells was higher in HRs. Activation of cTfh2 cells was specifically stimulated by PvDBPII antigen. In cTfh2-MBC co-cultures, proliferation and activation of cTfh2 cells were detected after receiving signal from MBCs. These activated cTfh2 cells then promoted MBC differentiation into antibody secreting cells (ASCs) which secreted anti-PvDBPII IgG. A decrease in cTfh2 cell activation was observed upon the addition of IFN-γ to the co-cultures. Importantly, cTfh2 cells played a role in producing anti-malarial specific antibodies. CONCLUSIONS/SIGNIFICANCE: This study demonstrated that activation of cTfh2 cells, marked by the upregulation of ICOS molecules, was notably observed in subjects who produced high titers of anti-PvDBPII antibodies in response to P. vivax infection. This was also seen in a few subjects who produced high levels of antibody with inhibitory function. The PvDBPII antigen specifically stimulated cTfh2 cell proliferation and activation. Additionally, interactions between cTfh2 cells and MBCs promoted both cTfh2 activation and anti-PvDBPII antibody secretion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.